0 item $0.00

Molecular Proteomics

Using quantitative proteomics to study the molecular function of secreted factors and extracellular vesicles in cancer, cardiometabolic disease and normal physiology

Read more

Laboratory head

i Profile of author

Latest Achievements

Helen Amelia Hains Fellow and Baker Fellow

President, Australia and New Zealand Society of Extracellular Vesicles

Australian Field Leader (outright) – Proteins, Proteomics (Australian Research Magazine)

Chair, International Society of Extracellular Vesicles Congress (2024)

Highly Cited Researchers 2020 (top 1%) by Stanford University citation impact (2021)

Read full biography
Associate Professor David Greening Baker Institute Fellow
We use a multi-disciplinary approach to understand the molecular function of extracellular vesicles incorporating proteomics, cell biology, molecular biology, and physiology, with the goal of identifying new deliverable therapeutic targets.


What is proteomics?     Collaborate with us

About the Molecular Proteomics laboratory

The Molecular Proteomics laboratory is focused on understanding the molecular function of nano-sized biological extracellular vesicles (EVs) and how their intercellular signalling is important in normal cardiac physiology and pathologies, with the goal of engineering EVs to overcome limitations in their therapeutic application and identifying new deliverable therapeutic targets. The advanced-nano approaches developed in our lab have identified novel regulators of secretome (cell-derived secreted factors) and EV biology and have utilised this knowledge for commercial and translational potential.

Extracellular vesicles are sophisticated signalling mediators, transporting select RNA and protein cargo. As secreted vesicles they have the capacity to enable intercellular communication and have become the focus of exponentially growing interest, both to study their functions and to understand ways to use them in the development of minimally invasive diagnostics. Importantly, EVs are released into biological fluids including blood, urine, uterine fluid, and protect their cargo against degradation and denaturation in the extracellular environment.

We are particularly interested in studying dynamic changes in EVs associated with lipids, proteins, protein post-translational modifications, and their membrane surface composition, and understanding how EVs mediate function to ultimately shape cellular physiology. We primarily focus on cardiometabolic disease (fibrotic processes during myocardial infarction and hypertension), implantation biology and molecular events associated with implantation and receptivity (embryo-endometrial cross-talk) and cancer progression. It is crucial to define EVs and understand the molecular mechanisms of their signalling and reprogramming to develop better approaches to investigate the many functions of cell communication, including in normal physiology and how they contribute to disease. This knowledge will lead to design of nano-carriers for the targeted and selective delivery to target organs/cells, define mechanisms of delivery and reprogramming of target cells, and development of novel therapeutics targeted to intercellular signalling.

We use a multi-disciplinary approach to understand the molecular function of EVs incorporating advanced proteomics, lipidomics, cell biology, molecular biology, nanomaterials, nanobiotechnology, regenerative cell biology, physiology, and experts in molecular therapies with the goal of identifying new deliverable therapeutic targets and facilitate effective engineered nanoparticles for next generation cell-free therapies.

The Molecular Proteomics team

Positions available

We offer projects in each of these areas, and a specific topic will be designed to cater for the interests and skills of a candidate. A prospective student will be a part of a successful multidisciplinary research team of molecular biologists, cell biologists, proteomics, nanomaterials, extracellular vesicles, and clinical scientists, and will gain experience in quantitative omics technologies (including proteomics), cardiovascular disease, cell biology, molecular biology and biochemistry.

We have University placements through La Trobe University and University of Melbourne. Contact us for more information...

Student projects     Lab publications

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more